Researchers have found a way to track the formation of soluble amyloid beta peptide aggregates in lab samples. The aggregates are implicated in the onset of Alzheimer’s disease.
Researchers have found a way to track the formation of soluble amyloid beta peptide aggregates in lab samples. The aggregates are implicated in the onset of Alzheimer’s disease.